Literature DB >> 27903721

Cross Talk Between Brain Innate Immunity and Serotonin Signaling Underlies Depressive-Like Behavior Induced by Alzheimer's Amyloid-β Oligomers in Mice.

Jose Henrique Ledo1, Estefania P Azevedo1, Danielle Beckman1, Felipe C Ribeiro1, Luis E Santos2, Daniela S Razolli3, Grasielle C Kincheski1, Helen M Melo1, Maria Bellio4, Antonio L Teixeira5, Licio A Velloso3, Debora Foguel1, Fernanda G De Felice1,6, Sergio T Ferreira7,2.   

Abstract

Considerable clinical and epidemiological evidence links Alzheimer's disease (AD) and depression. However, the molecular mechanisms underlying this connection are largely unknown. We reported recently that soluble Aβ oligomers (AβOs), toxins that accumulate in AD brains and are thought to instigate synapse damage and memory loss, induce depressive-like behavior in mice. Here, we report that the mechanism underlying this action involves AβO-induced microglial activation, aberrant TNF-α signaling, and decreased brain serotonin levels. Inactivation or ablation of microglia blocked the increase in brain TNF-α and abolished depressive-like behavior induced by AβOs. Significantly, we identified serotonin as a negative regulator of microglial activation. Finally, AβOs failed to induce depressive-like behavior in Toll-like receptor 4-deficient mice and in mice harboring a nonfunctional TLR4 variant in myeloid cells. Results establish that AβOs trigger depressive-like behavior via a double impact on brain serotonin levels and microglial activation, unveiling a cross talk between brain innate immunity and serotonergic signaling as a key player in mood alterations in AD. SIGNIFICANCE STATEMENT: Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the main cause of dementia in the world. Brain accumulation of amyloid-β oligomers (AβOs) is a major feature in the pathogenesis of AD. Although clinical and epidemiological data suggest a strong connection between AD and depression, the underlying mechanisms linking these two disorders remain largely unknown. Here, we report that aberrant activation of the brain innate immunity and decreased serotonergic tonus in the brain are key players in AβO-induced depressive-like behavior in mice. Our findings may open up new possibilities for the development of effective therapeutics for AD and depression aimed at modulating microglial function.
Copyright © 2016 the authors 0270-6474/16/3612106-11$15.00/0.

Entities:  

Keywords:  Alzheimer's; depression; inflammation; microglia; serotonin

Mesh:

Substances:

Year:  2016        PMID: 27903721      PMCID: PMC6601978          DOI: 10.1523/JNEUROSCI.1269-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  40 in total

1.  Immunomodulation via Toll-like Receptor 9: An Adjunct Therapy Strategy against Alzheimer's Disease?

Authors:  Maria Clara Selles; Juliana Tiemi Sato Fortuna; Luís Eduardo Santos
Journal:  J Neurosci       Date:  2017-05-10       Impact factor: 6.167

Review 2.  Serotonergic system, cognition, and BPSD in Alzheimer's disease.

Authors:  Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong
Journal:  Neurosci Lett       Date:  2019-04-01       Impact factor: 3.046

3.  Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.

Authors:  Izumi Maezawa; Hai M Nguyen; Jacopo Di Lucente; David Paul Jenkins; Vikrant Singh; Silvia Hilt; Kyoungmi Kim; Srikant Rangaraju; Allan I Levey; Heike Wulff; Lee-Way Jin
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

4.  Sex-specific effects of developmental exposure to polychlorinated biphenyls on neuroimmune and dopaminergic endpoints in adolescent rats.

Authors:  Deborah A Liberman; Katherine A Walker; Andrea C Gore; Margaret R Bell
Journal:  Neurotoxicol Teratol       Date:  2020-04-04       Impact factor: 3.763

5.  Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers.

Authors:  Mariana A de Godoy; Leonardo M Saraiva; Luiza R P de Carvalho; Andreia Vasconcelos-Dos-Santos; Hellen J V Beiral; Alane Bernardo Ramos; Livian R de Paula Silva; Renata B Leal; Victor H S Monteiro; Carolina V Braga; Carlla A de Araujo-Silva; Leandro C Sinis; Victor Bodart-Santos; Tais Hanae Kasai-Brunswick; Carolina de Lima Alcantara; Ana Paula C A Lima; Narcisa L da Cunha-E Silva; Antonio Galina; Adalberto Vieyra; Fernanda G De Felice; Rosalia Mendez-Otero; Sergio T Ferreira
Journal:  J Biol Chem       Date:  2017-12-28       Impact factor: 5.157

6.  Cronobacter sakazakii Infection in Early Postnatal Rats Impaired Contextual-Associated Learning: a Putative Role of C5a-Mediated NF-κβ and ASK1 Pathways.

Authors:  Ponnusamy Vinay; Christopher Karen; Krishnaswamy Balamurugan; Koilmani Emmanuvel Rajan
Journal:  J Mol Neurosci       Date:  2020-06-21       Impact factor: 3.444

7.  The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathway.

Authors:  Angela Maria Casaril; Micaela Domingues; Suely Ribeiro Bampi; Darling de Andrade Lourenço; Nathalia Batista Padilha; Eder João Lenardão; Mariana Sonego; Fabiana Kommling Seixas; Tiago Collares; Cristina Wayne Nogueira; Robert Dantzer; Lucielli Savegnago
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

8.  Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.

Authors:  Jacqueline London; Claude Rouch; Linh Chi Bui; Elodie Assayag; Benoit Souchet; Fabrice Daubigney; Hind Medjaoui; Serge Luquet; Christophe Magnan; Jean Maurice Delabar; Julien Dairou; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2017-05-25       Impact factor: 5.590

9.  Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.

Authors:  Jordano Brito-Moreira; Mychael V Lourenco; Mauricio M Oliveira; Felipe C Ribeiro; José Henrique Ledo; Luan P Diniz; Juliana F S Vital; Margaret H Magdesian; Helen M Melo; Fernanda Barros-Aragão; Jorge M de Souza; Soniza V Alves-Leon; Flavia C A Gomes; Julia R Clarke; Cláudia P Figueiredo; Fernanda G De Felice; Sergio T Ferreira
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

Review 10.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.